Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Bonsack

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|May 9, 2018
PRAME peptide-specific CD8<sup>+</sup> T cells represent the predominant response against leukemia-associated antigens in healthy individualsSarah Matko, Julia Manderla, Maria Bonsack, et al.
Cell Systems|July 2, 2018
MHCflurry: Open-Source Class I MHC Binding Affinity PredictionTimothy J O'Donnell, Alex Rubinsteyn, Maria Bonsack, et al.
Frontiers in Immunology|November 7, 2022
Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cellsNitya Mohan, Kathrin Wellach, Ceren Özerdem, et al.
Cancer Immunology Research|March 24, 2019
Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC-Peptide Binding Data SetMaria Bonsack, Stephanie Hoppe, Jan Winter, et al.
International Journal of Molecular Sciences|February 11, 2023
Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of GliomaYibin Liu, Anna Keib, Brigitte Neuber, et al.
Proteomics|April 1, 2018
A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell EpitopesRenata Blatnik, Nitya Mohan, Maria Bonsack, et al.
Cancer Immunology Research|December 25, 2019
High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggetsXiaoshan M Shao, Rohit Bhattacharya, Justin Huang, et al.
Nature Communications|September 22, 2020
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolutionAlexej Ballhausen, Moritz Jakob Przybilla, Michael Jendrusch, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|May 9, 2018
PRAME peptide-specific CD8<sup>+</sup> T cells represent the predominant response against leukemia-associated antigens in healthy individualsSarah Matko, Julia Manderla, Maria Bonsack, et al.
Cell Systems|July 2, 2018
MHCflurry: Open-Source Class I MHC Binding Affinity PredictionTimothy J O'Donnell, Alex Rubinsteyn, Maria Bonsack, et al.
Frontiers in Immunology|November 7, 2022
Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cellsNitya Mohan, Kathrin Wellach, Ceren Özerdem, et al.
Cancer Immunology Research|March 24, 2019
Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC-Peptide Binding Data SetMaria Bonsack, Stephanie Hoppe, Jan Winter, et al.
International Journal of Molecular Sciences|February 11, 2023
Definition and Characterization of SOX11-Derived T Cell Epitopes towards Immunotherapy of GliomaYibin Liu, Anna Keib, Brigitte Neuber, et al.
Proteomics|April 1, 2018
A Targeted LC-MS Strategy for Low-Abundant HLA Class-I-Presented Peptide Detection Identifies Novel Human Papillomavirus T-Cell EpitopesRenata Blatnik, Nitya Mohan, Maria Bonsack, et al.
Cancer Immunology Research|December 25, 2019
High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggetsXiaoshan M Shao, Rohit Bhattacharya, Justin Huang, et al.
Nature Communications|September 22, 2020
The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolutionAlexej Ballhausen, Moritz Jakob Przybilla, Michael Jendrusch, et al.
Pageof 1